论文信息 - In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer - 字舞流文

In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer

L. Rushworth | H. Leung | M. Bushell | W. Clark | Rachana Patel | R. Shaw | Peter Repiscak | V. Harle | Holly Hall